A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age
Titel:
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age
Auteur:
Hegmann, Theresa E. Walter, Emmanuel B. Smith, Michael J. Campbell, James El Sahly, Hana M. Whitaker, Jennifer A. Creech, C. Buddy Ustyugova, Irina V. Goncalvez, Ana P. Pandey, Aseem Alefantis, Timothy Sridhar, Saranya Honda-Okubo, Yoshikazu Petrovsky, Nikolai Frey, Sharon E. Abate, Getahun Paulsen, Grant Anderson, Evan J. Rostad, Christina A. Rouphael, Nadine Makhene, Mamodikoe Roberts, Paul C. Tuyishimire, Bonifride Bryant, Christopher Winokur, Patricia